Anthera Pharmaceuticals Inc Watch

EX-10.1

from 8-K 2 pages June 15, 2018 Personal and Confidential J. Craig Thompson Re: Adjustment to Terms of Employment; Notice of Termination

12/34/56

EX-10.41

from 10-K 3 pages Termination of Lease Agreement

12/34/56

EX-10.39

from 10-K 11 pages Employment Agreement

12/34/56

EX-10.38

from 10-K 11 pages Employment Agreement

12/34/56

EX-10.37

from 10-K 11 pages Employment Agreement

12/34/56

EX-10.36

from 10-K 11 pages Amended and Restated Employment Agreement

12/34/56

EX-10.35

from 10-K 11 pages Amended and Restated Employment Agreement

12/34/56

EX-10.3

from 8-K 16 pages Anthera Pharmaceuticals, Inc. Warrant to Purchase Common Stock

12/34/56

EX-10.2

from 8-K 39 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 97 pages Securities Purchase Agreement

12/34/56

EX-10.2

from 10-Q 7 pages Basic Sublease Terms

12/34/56

EX-10.1

from 8-K 2 pages [Remainder of Page Left Blank Intentionally.]

12/34/56

EX-10.43

from 10-K 1 page December 6, 2016 1. Position. Effective December 6, 2016, Your New Title Is President and CEO, Reporting Directly to the Executive Chairman of the Board

12/34/56

EX-10.4

from 10-Q 2 pages 1. Position. the Company Will Employ You in the Position of Chief Medical Officer (Cmo) Reporting to the Company’s President & COO. Your Employment Will Commence on or About September 1, 2016

12/34/56

EX-10.1

from 8-K 36 pages Subscription Agreement

12/34/56

EX-10.1

from 10-Q ~1 page April 1, 2016 1. Position. Effective April 1, 2016, Your New Title Is Interim Chief Medical Officer, Reporting Directly to the Company’s President & Chief Operating Officer

12/34/56

EX-10.1

from 8-K 3 pages Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward, California 94545 April 27, 2016

12/34/56

EX-10.1

from 8-K 31 pages Anthera Pharmaceuticals, Inc. $25,000,000 Sales Agreement

12/34/56

EX-10.40

from 10-K 17 pages Employment Agreement

12/34/56

EX-10.39

from 10-K 17 pages Employment Agreement

12/34/56